ABSI Latest Press Releases

-- October 27, 2026 --

Absci to Participate in Upcoming Investor Conferences Globe Newswire 8:00 AM

-- October 21, 2026 --

AI Can Design Antibodies Faster Than Anyone Can Check Them for Immune Risk. That Gap Is Starting to Close. Globe Newswire 10:00 AM

-- October 14, 2026 --

AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test Globe Newswire 9:45 AM

-- October 13, 2026 --

Absci to Report Business Updates and Third Quarter 2026 Financial and Operating Results on November 12, 2026 Globe Newswire 8:00 AM

-- September 24, 2026 --

Absci Announces Preliminary Details for Phase 2 STORYLINE Trial of AI-Designed Antibody ABS-201 for Endometriosis Globe Newswire 8:00 AM

-- September 1, 2026 --

Absci to Participate in Upcoming Investor Conferences Globe Newswire 8:00 AM

-- August 19, 2026 --

Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does. Globe Newswire 8:56 AM

-- August 11, 2026 --

Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results Globe Newswire 4:05 PM

-- July 14, 2026 --

Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026 Globe Newswire 4:05 PM

-- July 6, 2026 --

As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models PRNewswire 8:55 AM

The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel PRNewswire 8:45 AM

-- June 24, 2026 --

Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors Globe Newswire 6:35 AM

Absci Announces Positive Interim Phase 1 Data from the HEADLINE Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) Globe Newswire 6:30 AM

-- June 16, 2026 --

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It PRNewswire 8:45 AM

-- June 12, 2026 --

MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery Business Wire 9:00 AM

Market Data Delayed 15 Minutes